MedPath

Probiotic Supplement as Treatment for Students With ADHD

Not Applicable
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
Dietary Supplement: Probiotic
Dietary Supplement: Placebo
Registration Number
NCT02908802
Lead Sponsor
Tel Hai College
Brief Summary

Subjects will answer the following questionnaire and tests:

* Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)

* Demographic Questionnaire - composed by the researchers

* Family Eating Habits Questionnaire (FEAHQ-33)

* Food Frequency Questionnaire (FFQ)

* Test MOXO

The subjects will take the study product for six months.

After six months the subject will fill once again all the questionnaires.

Detailed Description

Computerized performance test MOXO - the test has been developed in Israel by Neurotech Company. The test's goal is to assess and define a participant's performance according to the four indices of Attention Deficit Hyperactivity Disorder: Attention, Hyperactivity, Impulsivity, and Timing with adjustment for age.

Subjects will answer the following questionnaire and tests:

* Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)

* Demographic Questionnaire - composed by the researchers

* Family Eating Habits Questionnaire (FEAHQ-33)

* Food Frequency Questionnaire (FFQ)

* Test MOXO

The subjects will take the study product for six months.

After six months the subject will fill once again all the questionnaires.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Students registered in the college's Support Center for Students with Learning Disabilities and who have been diagnosed by a computerized didactic assessment -MATAL - as well as an attention diagnosis by a psychiatrist or a neurologist,

  • Students who are not treated by medication or alternative treatment,

  • Students who are not due to complete their education at Tel Hai College during the study period,

  • Students who have signed on an informed consent form,

  • No dairy intolerance (student can consume milk without any adverse effects),

  • No soy allergy,

  • Not currently taking any antibiotics or probiotics,

  • Not pregnant or planning to become pregnant during the study period,

  • Not been diagnosed with any of the following:

    • Cancer
    • HIV/AIDS
    • Crohn's disease
    • Ulcerative colitis
    • Immune compromised illness
    • Other serious illness
Exclusion Criteria
  • Students treated by any type of treatment for Attention Deficit Hyperactivity Disorder,
  • Students who have not been assessed by MATAL and a psychiatrist,
  • Students who take antibiotics.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ProbioticProbioticProbiotic capsules: two capsules twice a day
PlaceboPlaceboProbiotic capsules without the active ingredient: two capsules twice a day
Primary Outcome Measures
NameTimeMethod
Reduce symptoms of attention deficit measured by MOXO testSix month

After six month of treatment reduce symptoms of attention deficit will be measured by MOXO test

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath